Spojené státy - angličtina - NLM (National Library of Medicine)

cosette pharmaceuticals, inc. - hydrocortisone valerate (unii: 68717p8fuz) (hydrocortisone - unii:wi4x0x7bpj) - hydrocortisone valerate 2 mg in 1 g - hydrocortisone valerate cream usp, 0.2% is a medium potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses in adult patients. hydrocortisone valerate cream usp, 0.2% is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Malta - angličtina - Medicines Authority

panpharma z.i. du clairay, 35133 luitre, france - hydrocortisone sodium, succinate - powder for solution for infusion or injection - hydrocortisone sodium succinate 133.7 mg - corticosteroids for systemic use

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - hydrocortisone, quantity: 20 mg - tablet, uncoated - excipient ingredients: povidone; magnesium stearate; macrogol 8000; lactose monohydrate; maize starch - indications as at 6 may 1992: hydrocortisone is indicated for replacement therapy in addison's disease or chronic adrenocortical insufficiency secondary to hypopituitarism.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - hydrocortisone, quantity: 4 mg - tablet, uncoated - excipient ingredients: maize starch; magnesium stearate; lactose monohydrate; povidone - indications as at 6 may 1992: hydrocortisone is indicated for replacement therapy in addison's disease or chronic adrenocortical insufficiency secondary to hypopituitarism.

Spojené státy - angličtina - NLM (National Library of Medicine)

hikma pharmaceutical - cortisone acetate (unii: 883wkn7w8x) (cortisone - unii:v27w9254fz) - cortisone acetate 25 mg - 1. endocrine disorders primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance). congenital adrenal hyperplasia nonsuppurative thyroiditis hypercalcemia associated with cancer 2. rheumatic disorders as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: psoriatic arthritis rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy) ankylosing spondylitis acute and subacute bursitis acute nonspecific tenosynovitis acute gouty arthritis post-traumatic osteoarthritis synovitis of osteoarthritis epicondylitis 3. collagen diseases during an exacerbation or as maintenance therapy in selected cases of: systemic lupus erythematosus acute rheumatic carditis systemic dermatomyositis

Spojené státy - angličtina - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - cortisone acetate (unii: 883wkn7w8x) (cortisone - unii:v27w9254fz) - cortisone acetate 25 mg - 1.  endocrine disorders primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance). congenital adrenal hyperplasia nonsuppurative thyroiditis hypercalcemia associated with cancer 2.  rheumatic disorders as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: psoriatic arthritis rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy) ankylosing spondylitis acute and subacute bursitis acute nonspecific tenosynovitis acute gouty arthritis post-traumatic osteoarthritis synovitis of osteoarthritis epicondylitis 3.  collagen diseases during an exacerbation or as maintenance therapy in selected cases of: systemic lupus erythematosus acute rheumatic carditis systemic dermatomyosit

Spojené státy - angličtina - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - cortisone acetate (unii: 883wkn7w8x) (cortisone - unii:v27w9254fz) - cortisone acetate 25 mg - - endocrine disorders primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance). congenital adrenal hyperplasia nonsuppurative thyroiditis hypercalcemia associated with cancer - rheumatic disorders as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: psoriatic arthritis rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy) ankylosing spondylitis acute and subacute bursitis acute nonspecific tenosynovitis acute gouty arthritis post-traumatic osteoarthritis synovitis of osteoarthritis epicondylitis - collagen diseases during an exacerbation or as maintenance therapy in selected cases of: systemic lupus erythematosus acute rheumatic carditis systemic dermat

Spojené státy - angličtina - NLM (National Library of Medicine)

major pharmaceuticals - hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - hydrocortisone 20 mg - - endocrine disorders  primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance)  congenital adrenal hyperplasia  nonsuppurative thyroiditis  hypercalcemia associated with cancer -  primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance) -  congenital adrenal hyperplasia -  nonsuppurative thyroiditis -  hypercalcemia associated with cancer - rheumatic disorders  as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in:  psoriatic arthritis  rheumatoid arthritis, including juvenile rheumatoid art

Spojené státy - angličtina - NLM (National Library of Medicine)

stat rx usa llc - hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - hydrocortisone 20 mg - - endocrine disorders   primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance)   congenital adrenal hyperplasia   nonsuppurative thyroiditis   hypercalcemia associated with cancer - rheumatic disorders   as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in:   psoriatic arthritis   rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy):   ankylosing spondylitis   acute and subacute bursitis   acute nonspecific tenosynovitis   acute gouty arthritis   post-traumatic osteoarthritis   synovitis or osteoarthritis   epicondylitis - collagen diseases   during an exacerbation or as maintenance therapy in selected cases of:   systemic lupus erythematosus

Spojené státy - angličtina - NLM (National Library of Medicine)

physicians total care, inc. - hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - hydrocortisone 20 mg - - endocrine disorders   primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance)   congenital adrenal hyperplasia   nonsuppurative thyroiditis   hypercalcemia associated with cancer - rheumatic disorders   as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in:   psoriatic arthritis   rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy):   ankylosing spondylitis   acute and subacute bursitis   acute nonspecific tenosynovitis   acute gouty arthritis   post-traumatic osteoarthritis   synovitis or osteoarthritis   epicondylitis - collagen diseases   during an exacerbation or as maintenance therapy in selected cases of:   systemic lupus erythematosus